Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel Anti-Alzheimer’s Therapeutic Molecules Targeting Amyloid Precursor Protein Processing
Md. Sahab Uddin, Md. Tanvir Kabir, Philippe Jeandet, et al.
Oxidative Medicine and Cellular Longevity (2020) Vol. 2020, pp. 1-19
Open Access | Times Cited: 59

Showing 1-25 of 59 citing articles:

Role of Phenolic Compounds in Human Disease: Current Knowledge and Future Prospects
Md. Mominur Rahman, Md. Saidur Rahaman, Md. Rezaul Islam, et al.
Molecules (2021) Vol. 27, Iss. 1, pp. 233-233
Open Access | Times Cited: 550
Physiology and pharmacology of amyloid precursor protein
Yoonsuk Cho, Han‐Gyu Bae, Eitan Okun, et al.
Pharmacology & Therapeutics (2022) Vol. 235, pp. 108122-108122
Closed Access | Times Cited: 78
Molecular Mechanisms of ER Stress and UPR in the Pathogenesis of Alzheimer’s Disease
Md. Sahab Uddin, Devesh Tewari, Gaurav Sharma, et al.
Molecular Neurobiology (2020) Vol. 57, Iss. 7, pp. 2902-2919
Closed Access | Times Cited: 136
Revisiting the Amyloid Cascade Hypothesis: From Anti-Aβ Therapeutics to Auspicious New Ways for Alzheimer’s Disease
Md. Sahab Uddin, Md. Tanvir Kabir, Md. Sohanur Rahman, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 16, pp. 5858-5858
Open Access | Times Cited: 91
Molecular Mechanisms of Metal Toxicity in the Pathogenesis of Alzheimer’s Disease
Md. Tanvir Kabir, Md. Sahab Uddin, Sonia Zaman, et al.
Molecular Neurobiology (2020) Vol. 58, Iss. 1, pp. 1-20
Closed Access | Times Cited: 90
Chromosome-scale assembly of the Dendrobium chrysotoxum genome enhances the understanding of orchid evolution
Yongxia Zhang, Guoqiang Zhang, Diyang Zhang, et al.
Horticulture Research (2021) Vol. 8, Iss. 1
Open Access | Times Cited: 71
Diabetic Retinopathy in the Aging Population: A Perspective of Pathogenesis and Treatment
Sameer P. Leley, Thomas A. Ciulla, Ashay D. Bhatwadekar
Clinical Interventions in Aging (2021) Vol. Volume 16, pp. 1367-1378
Open Access | Times Cited: 69
The role of mitochondria dysfunction and hepatic senescence in NAFLD development and progression
Siarhei A. Dabravolski, Evgeny E. Bezsonov, Alexander N. Orekhov
Biomedicine & Pharmacotherapy (2021) Vol. 142, pp. 112041-112041
Open Access | Times Cited: 59
Nanomedicine in the Management of Alzheimer’s Disease: State-of-the-Art
Shehla Nasar Mir Najib Ullah, Obaid Afzal, Abdulmalik Saleh Alfawaz Altamimi, et al.
Biomedicines (2023) Vol. 11, Iss. 6, pp. 1752-1752
Open Access | Times Cited: 39
Revisiting the role of brain and peripheral Aβ in the pathogenesis of Alzheimer's disease
Md. Sahab Uddin, Md. Tanvir Kabir, Devesh Tewari, et al.
Journal of the Neurological Sciences (2020) Vol. 416, pp. 116974-116974
Closed Access | Times Cited: 64
Multi-Target Drug Candidates for Multifactorial Alzheimer’s Disease: AChE and NMDAR as Molecular Targets
Md. Sahab Uddin, Abdullah Al Mamun, Md. Tanvir Kabir, et al.
Molecular Neurobiology (2020) Vol. 58, Iss. 1, pp. 281-303
Closed Access | Times Cited: 64
Multifarious roles of mTOR signaling in cognitive aging and cerebrovascular dysfunction of Alzheimer's disease
Md. Sahab Uddin, Md. Ataur Rahman, Md. Tanvir Kabir, et al.
IUBMB Life (2020) Vol. 72, Iss. 9, pp. 1843-1855
Open Access | Times Cited: 54
Novel Applications of NSAIDs: Insight and Future Perspectives in Cardiovascular, Neurodegenerative, Diabetes and Cancer Disease Therapy
Edmundas Kaduševičius
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 12, pp. 6637-6637
Open Access | Times Cited: 46
Exposure of metal toxicity in Alzheimer’s disease: An extensive review
Fahadul Islam, Sheikh Shohag, Shomaya Akhter, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 37
Emerging Proof of Protein Misfolding and Interactions in Multifactorial Alzheimer's Disease
Md. Sahab Uddin, Abdullah Al Mamun, Md. Ataur Rahman, et al.
Current Topics in Medicinal Chemistry (2020) Vol. 20, Iss. 26, pp. 2380-2390
Closed Access | Times Cited: 50
Exploring the Role of PSEN Mutations in the Pathogenesis of Alzheimer’s Disease
Md. Tanvir Kabir, Md. Sahab Uddin, Jinnat Ruksana Setu, et al.
Neurotoxicity Research (2020) Vol. 38, Iss. 4, pp. 833-849
Closed Access | Times Cited: 48
Molecular Insight into the Therapeutic Promise of TargetingAPOE4for Alzheimer’s Disease
Abdullah Al Mamun, Md. Sahab Uddin, Md. Fahim Bin Bashar, et al.
Oxidative Medicine and Cellular Longevity (2020) Vol. 2020, pp. 1-16
Open Access | Times Cited: 47
Cancer Chemotherapy Related Cognitive Impairment and the Impact of the Alzheimer’s Disease Risk Factor APOE
Harvey R. Fernandez, Ashima Varma, Sarah A. Flowers, et al.
Cancers (2020) Vol. 12, Iss. 12, pp. 3842-3842
Open Access | Times Cited: 42
CREB nuclear transcription activity as a targeting factor in the treatment of diabetes and diabetes complications
Khaled Benchoula, Ishwar S. Parhar, Priya Madhavan, et al.
Biochemical Pharmacology (2021) Vol. 188, pp. 114531-114531
Closed Access | Times Cited: 33
Emerging Promise of Cannabinoids for the Management of Pain and Associated Neuropathological Alterations in Alzheimer’s Disease
Md. Sahab Uddin, Abdullah Al Mamun, Dewan Md. Sumsuzzman, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 34
Dietary quercetin attenuates depressive-like behaviors by inhibiting astrocyte reactivation in response to stress
Jiajia Zhang, Lijuan Ning, Junping Wang
Biochemical and Biophysical Research Communications (2020) Vol. 533, Iss. 4, pp. 1338-1346
Closed Access | Times Cited: 33
APOE4 is a Risk Factor and Potential Therapeutic Target for Alzheimer's Disease
Gunel Ayyubova
CNS & Neurological Disorders - Drug Targets (2023) Vol. 23, Iss. 3, pp. 342-352
Closed Access | Times Cited: 11
Therapeutic considerations of bioactive compounds in Alzheimer's disease and Parkinson's disease: Dissecting the molecular pathways
Banashree Chetia Phukan, Rubina Roy, Indira Gahatraj, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 12, pp. 5657-5699
Open Access | Times Cited: 11
Emerging Promise of Immunotherapy for Alzheimer’s Disease: A New Hope for the Development of Alzheimer’s Vaccine
Md. Tanvir Kabir, Md. Sahab Uddin, Bijo Mathew, et al.
Current Topics in Medicinal Chemistry (2020) Vol. 20, Iss. 13, pp. 1214-1234
Closed Access | Times Cited: 28
Exercise as Potential Therapeutic Target to Modulate Alzheimer’s Disease Pathology in APOE ε4 Carriers: A Systematic Review
Sevilay Tokgöz, Jurgen A.H.R. Claassen
Cardiology and Therapy (2021) Vol. 10, Iss. 1, pp. 67-88
Open Access | Times Cited: 25
Page 1 - Next Page

Scroll to top